{"status": "Ok", "redirect_url": "https://investors.pfizer.com/Investors/news-events/News/news-details/2026/FDA-Approves-Pfizers-IBRANCE-Regimen-for-HR-HER2-Metastatic-Breast-Cancer-Frontline-Maintenance/default.aspx", "message": "News view counter 814670 successfully enlarged"}